DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $484,042 | -18.9% | 1,951 | -21.5% | 0.05% | -15.9% |
Q2 2023 | $596,640 | -6.0% | 2,486 | -1.3% | 0.06% | -10.0% |
Q1 2023 | $634,888 | -7.5% | 2,519 | -2.6% | 0.07% | -10.3% |
Q4 2022 | $686,375 | +2.1% | 2,586 | -0.5% | 0.08% | -8.2% |
Q3 2022 | $672,000 | -17.1% | 2,600 | -18.7% | 0.08% | -12.4% |
Q2 2022 | $811,000 | -13.0% | 3,199 | +0.7% | 0.10% | -2.0% |
Q1 2022 | $932,000 | -10.8% | 3,177 | 0.0% | 0.10% | -4.8% |
Q4 2021 | $1,045,000 | +7.7% | 3,177 | -0.3% | 0.10% | -3.7% |
Q3 2021 | $970,000 | +110.4% | 3,185 | +87.4% | 0.11% | +116.0% |
Q2 2021 | $461,000 | +20.4% | 1,700 | 0.0% | 0.05% | +13.6% |
Q1 2021 | $383,000 | -4.2% | 1,700 | -5.6% | 0.04% | -10.2% |
Q4 2020 | $400,000 | -0.7% | 1,800 | -4.0% | 0.05% | -9.3% |
Q3 2020 | $403,000 | +0.2% | 1,875 | -17.6% | 0.05% | -5.3% |
Q2 2020 | $402,000 | +28.0% | 2,275 | 0.0% | 0.06% | +9.6% |
Q1 2020 | $314,000 | -10.0% | 2,275 | 0.0% | 0.05% | +23.8% |
Q4 2019 | $349,000 | +1.7% | 2,275 | -4.2% | 0.04% | -4.5% |
Q3 2019 | $343,000 | +5.5% | 2,375 | +4.4% | 0.04% | +4.8% |
Q2 2019 | $325,000 | +8.3% | 2,275 | 0.0% | 0.04% | +5.0% |
Q1 2019 | $300,000 | +35.1% | 2,275 | +5.8% | 0.04% | +21.2% |
Q4 2018 | $222,000 | -7.5% | 2,150 | -2.5% | 0.03% | +3.1% |
Q3 2018 | $240,000 | +13.2% | 2,206 | +2.6% | 0.03% | +6.7% |
Q2 2018 | $212,000 | -14.5% | 2,150 | -15.0% | 0.03% | -16.7% |
Q1 2018 | $248,000 | +21.6% | 2,530 | +15.0% | 0.04% | +24.1% |
Q4 2017 | $204,000 | -26.9% | 2,200 | -32.3% | 0.03% | -29.3% |
Q3 2017 | $279,000 | – | 3,250 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |